Glioblastoma study discovers protective role of metabolic enzyme,...
Researchers at The University of Texas MD Anderson Cancer Center have discovered a novel function for the metabolic enzyme...
MD Anderson researchers present new findings in targeted...
Several Phase II clinical trials conducted by researchers from The University of Texas MD Anderson Cancer Center show promising...
MD Anderson and other top U.S. cancer centers call for...
The University of Texas MD Anderson Cancer Center has united with fellow National Cancer Institute (NCI)-Designated Cancer Centers and...
New AI-based tool can find rare cell populations in large...
Researchers at The University of Texas MD Anderson Cancer Center have developed a first-of-its-kind artificial intelligence (AI)-based...
CPRIT renews funding for MD Anderson training program focused on...
Today, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded The University of Texas MD Anderson Cancer Center $4...
Combination therapy achieves high rates of response for...
ABSTRACT #7001
A combination of ponatinib and blinatumomab was found to be safe and highly effective in patients with newly...
Metabolic inhibitor IACS-6274 shows early antitumor effects...
ABSTRACT #3001
The glutaminase (GLS1) inhibitor IACS-6274, discovered and developed by The University of Texas MD Anderson Cancer...
MD Anderson and Refuge Biotechnologies collaborate to...
The University of Texas MD Anderson Cancer Center and Refuge Biotechnologies, Inc. today announced a strategic collaboration to...
NK cells with bispecific antibody show activity against...
Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific...
Mitochondrial enzyme found to block cell death pathway...
The mitochondrial enzyme dihydroorotate dehydrogenase (DHODH) plays an important and previously unknown role in blocking a form of...
MD Anderson and Broad Institute launch new translational...
The University of Texas MD Anderson Cancer Center and the Broad Institute of MIT and Harvard today announced the launch of a new...
Single-cell map of early stage lung cancer and normal lung...
Researchers at The University of Texas MD Anderson Cancer Center have developed a first-of-its-kind spatial atlas of early-stage lung...